Daiken Biomedical Co

Daiken Biomedical Co EBIT per Share

The EBIT per Share of Daiken Biomedical Co (7780.TWO) as of Oct 16, 2026 is 2.48 TWD. In the previous year, EBIT per Share was 3.40 TWD — a change of -27.06% (lower).

EBIT per Share

2.48TWD

YoY

-27.06%

Last updated:

EBIT per Share of Daiken Biomedical Co is 2024 2.48 TWD. EBIT per Share of Daiken Biomedical Co was 2023 3.40 TWD. It decreases by -27.06% lower compared to the previous year.

The Daiken Biomedical Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2022
1.87 TWD
Jan 1, 2023
3.40 TWD
Jan 1, 2024
2.48 TWD
Jan 1, 2025 (e)
5.53 TWD
Jan 1, 2026 (e)
12.60 TWD
Jan 1, 2027 (e)
17.95 TWD
The Daiken Biomedical Co EBIT per Share history
YEAREBIT per ShareYoY
est17.95TWD+42.46%
est12.60TWD+127.95%
est5.53TWD+122.72%
2.48TWD-27.06%
3.40TWD+81.57%
1.87TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Daiken Biomedical Co Stock analysis

What does Daiken Biomedical Co do? Daiken Biomedical Co Ltd is a company based in Taipei City, Taiwan, with its headquarters located in Taipei City. The company made its initial public offering (IPO) on October 28, 2024, and is listed under the ticker symbol 7780.TWO with ISIN TW0007780009. Daiken Biomedical operates in the health food sector, focusing on the research, development, and sales of health food products. The company's product portfolio includes fish oil, lutein, maca, bitter melon peptide cinnamon capsules, women's probiotics, good sleep sesamin, and high dietary fiber powder packets. Sales are conducted through multiple channels, including the company's official website, online platforms such as Momo, Shopee, and PChome, as well as physical retail locations like Watsons, FamilyMart, and Cosmetics. The firm primarily serves the Taiwan market, with operations centered within Taiwan. The company's website is https://www.daikenshop.com/. Daiken Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Daiken Biomedical Co stock

EBIT per Share of Daiken Biomedical Co is 2.48 TWD in 2024.

EBIT per Share of Daiken Biomedical Co changed from 3.40 TWD to 2.48 TWD, representing a -27.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Daiken Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Daiken Biomedical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Daiken Biomedical Co